Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07548164 · ClinicalTrials.gov registry record · Phase 3
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 224
- Enrollment target
NCT07548164: Recruiting Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07548164 is a Phase 3 study that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 224 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07548164, a Phase 3 study, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 224 participants
- Enrollment target
Study Summary
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
Interventions
- RADIATION Stereotactic Body Radiation Therapy
- DEVICE NanoKnife System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2026-04-16 |
| Est. Completion | 2029-04-16 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07548164
The ClinicalTrials.gov registry entry for NCT07548164 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Body Radiation Therapy is the first listed.
NCT07548164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07548164 about?
NCT07548164 is a clinical study titled "Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer". In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body rad...
What is the current status of trial NCT07548164?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 224 participants. The study started on 2026-04-16. Estimated completion is 2029-04-16.
What interventions are being tested in trial NCT07548164?
The interventions under investigation include: Stereotactic Body Radiation Therapy (RADIATION), NanoKnife System (DEVICE).
Who is sponsoring clinical trial NCT07548164?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.